Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,978 | 6,350 | 4,643 | 4,735 | 4,982 |
| Operating Income | -4,978 | -6,350 | -4,643 | -4,735 | -4,982 |
| Other Income | 220 | 9 | 1,268 | 764 | -370 |
| Pre-tax Income | -4,758 | -6,341 | -3,375 | -3,970 | -5,352 |
| Income Tax | N/A | 43 | 2 | 19 | N/A |
| Net Income Continuous | -4,758 | -6,384 | -3,377 | -3,990 | -5,352 |
| Net Income | $-4,758 | $-6,384 | $-3,377 | $-3,990 | $-5,352 |
| EPS Basic Total Ops | -0.08 | -0.10 | -0.06 | -0.07 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.11 | -0.06 | -0.07 | -0.09 |
| EPS Diluted Total Ops | -0.08 | -0.10 | -0.06 | -0.07 | -0.09 |
| EPS Diluted Continuous Ops | -0.08 | -0.11 | -0.06 | -0.07 | -0.09 |
| EBITDA(a) | $-4,906 | $-6,273 | $-4,572 | $-4,659 | $-4,905 |